Cleared Traditional

K211193 - BD Prevue II Peripheral Vascular Vascul...

K211193 is the FDA 510(k) clearance for BD Prevue II Peripheral Vascular Vascul... by Bard Access Systems, Inc. (C.R. Bard, Inc.). It is a Class 2 Radiology device (product code IYO) cleared through the Traditional 510(k) pathway after a 65-day FDA review.

K211193 · Bard Access Systems, Inc. (C.R. Bard, Inc.) · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
65d
Days
Class 2
Risk

K211193 is an FDA 510(k) clearance for the BD Prevue II Peripheral Vascular Vascular Access System. Classified as System, Imaging, Pulsed Echo, Ultrasonic (product code IYO), Class II - Special Controls.

Submitted by Bard Access Systems, Inc. (C.R. Bard, Inc.) (Salt Lake Ciy,, US). The FDA issued a Cleared decision on June 25, 2021 after a review of 65 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1560 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bard Access Systems, Inc. (C.R. Bard, Inc.) devices

Submission Details

510(k) Number K211193 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 21, 2021
Decision Date June 25, 2021
Days to Decision 65 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
42d faster than avg
Panel avg: 107d · This submission: 65d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IYO System, Imaging, Pulsed Echo, Ultrasonic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - IYO System, Imaging, Pulsed Echo, Ultrasonic

All 387
Devices cleared under the same product code (IYO) and FDA review panel - the closest regulatory comparables to K211193.
FibroScan 230
K212035 · Echosens · Jul 2021
SC1 Handheld Ultrasound Imaging System (Model: SC1)
K210468 · Fcu Co., Ltd. · Jul 2021
iSR'obot Mona Lisa 1.0
K203659 · Biobot Surgical Pte., Ltd. · Jul 2021
THD Procto Software System
K211623 · Thd Spa · Jun 2021
Palm Bladder Scanner - PBSV7.1
K210591 · Mianyang Meike Electronic Equipment Co., Ltd. · Jun 2021
Breast Volume Navigator (BVN) Model G-2000
K211098 · Metritrack, Inc. · May 2021